LATEST
Janel agreed to acquire EnCor BiotechnologynewNightfood Holdings acquired Jun Long Machine IndustrialnewClimb Global Solutions acquired NeoVADnewValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
ClosedPublished 1 Jul 2022

GSK plc /
Sierra Oncology

GSK completes acquisition of Sierra Oncology

Terms
Not stated
Stage
Closed
Buy side: GSK plc
Buy sideGSK plc
Source · 1 Jul 2022
See the source
Buy side: GSK plc
Buy sideGSK plc
01 / BuyerGSK plc
02 / TargetSierra Oncology
01

What happened

GSK plc completed its acquisition of Sierra Oncology, Inc. on July 1, 2022. Sierra Oncology became a wholly owned subsidiary of GSK.

Each eligible share of Sierra Oncology common stock converted into the right to receive $55.00 in cash, without interest.

02

The source

Everything on this page comes from the source below.

01
Source · Source

GSK completes acquisition of Sierra Oncology

This document is the source for the companies, stage and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Closed

    The source this page is built from.

  2. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.